Friday, Dec. 18, 2015, 77 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $24.26 to $4,955,373.00.

Highlighted Stocks Traded by Insiders:

Sonoco Products (SON) - FREE Research Report

Micali James M, who is Director at Sonoco Products, sold 4,828 shares at $41.87 on Dec. 18, 2015. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 4,828-share transaction.

The shares most recently traded at $39.81, down $2.06, or 5.17% since the insider transaction. Historical insider transactions for Sonoco Products go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 3,000

The average volume for Sonoco Products has been 513,400 shares per day over the past 30 days. Sonoco Products has a market cap of $4.1 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 9.79% year-to-date as of the close of trading on Friday.

Sonoco Products Company manufactures and sells industrial and consumer packaging products in North and South America, Europe, Australia, and Asia. The stock currently has a dividend yield of 3.45%. The company has a P/E ratio of 16.2. Currently, there are 3 analysts who rate Sonoco Products a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SON - FREE

TheStreet Quant Ratings rates Sonoco Products as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Sonoco Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Guess (GES) - FREE Research Report

Relich Michael, who is Coo at Guess, sold 11,855 shares at $20.42 on Dec. 18, 2015. Following this transaction, the Coo owned 71,944 shares meaning that the stake was reduced by 14.15% with the 11,855-share transaction.

The shares most recently traded at $19.38, down $1.04, or 5.37% since the insider transaction. Historical insider transactions for Guess go as follows:

  • 4-Week # shares bought: 650
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 650
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 650
  • 24-Week # shares sold: 20,000

The average volume for Guess has been 1.1 million shares per day over the past 30 days. Guess has a market cap of $1.7 billion and is part of the services sector and retail industry. Shares are down 6.74% year-to-date as of the close of trading on Friday.

Guess , Inc. designs, markets, distributes, and licenses lifestyle collections of contemporary apparel and accessories for men, women, and children that reflect the American lifestyle and European fashion sensibilities. The stock currently has a dividend yield of 4.5%. The company has a P/E ratio of 19.2. Currently, there are 3 analysts who rate Guess a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GES - FREE

TheStreet Quant Ratings rates Guess as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Guess Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Omnicell (OMCL) - FREE Research Report

Ngo Nhat H, who is Exec. VP, Strategy & Bus Dev. at Omnicell, sold 4,069 shares at $28.71 on Dec. 18, 2015. Following this transaction, the Exec. VP, Strategy & Bus Dev. owned 23,431 shares meaning that the stake was reduced by 14.8% with the 4,069-share transaction.

The shares most recently traded at $28.38, down $0.33, or 1.16% since the insider transaction. Historical insider transactions for Omnicell go as follows:

  • 4-Week # shares sold: 670
  • 12-Week # shares sold: 670
  • 24-Week # shares sold: 19,751

The average volume for Omnicell has been 251,600 shares per day over the past 30 days. Omnicell has a market cap of $1.0 billion and is part of the technology sector and computer software & services industry. Shares are down 14.67% year-to-date as of the close of trading on Friday.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates in two segments, Automation and Analytics, and Medication Adherence. The company has a P/E ratio of 33.1. Currently, there are 4 analysts who rate Omnicell a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OMCL - FREE

TheStreet Quant Ratings rates Omnicell as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Omnicell Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.